Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Raw Materials (2016 - 2025)

InspireMD's Raw Materials history spans 13 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 10.45% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.1 million, up 10.45%, while the annual FY2025 figure was $2.1 million, 10.45% up from the prior year.
  • Raw Materials reached $2.1 million in Q4 2025 per NSPR's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.3 million in Q3 2025 to a low of $581000.0 in Q3 2021.
  • Average Raw Materials over 5 years is $1.3 million, with a median of $999000.0 recorded in 2023.
  • Peak YoY movement for Raw Materials: decreased 26.64% in 2021, then surged 78.26% in 2024.
  • A 5-year view of Raw Materials shows it stood at $615000.0 in 2021, then skyrocketed by 51.54% to $932000.0 in 2022, then soared by 43.13% to $1.3 million in 2023, then surged by 43.48% to $1.9 million in 2024, then increased by 10.45% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Raw Materials are $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.2 million (Q2 2025).